Regulation of Tumor Angiogenesis by EZH2

While VEGF-targeted therapies are showing promise, new angiogenesis targets are needed to make additional gains. Here, we show that increased Zeste homologue 2 (EZH2) expression in either tumor cells or in tumor vasculature is predictive of poor clinical outcome. The increase in endothelial EZH2 is...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lu, Chunhua, Han, Hee Dong, Mangala, Lingegowda S., Ali-Fehmi, Rouba, Newton, Christopher S., Ozbun, Laurent, Armaiz-Pena, Guillermo N., Hu, Wei, Stone, Rebecca L., Munkarah, Adnan, Ravoori, Murali K., Shahzad, Mian M. K., Lee, Jeong-Won, Mora, Edna, Langley, Robert R., Carroll, Amy R., Matsuo, Koji, Spannuth, Whitney A., Schmandt, Rosemarie, Jennings, Nicholas B., Goodman, Blake W., Jaffe, Robert B., Nick, Alpa M., Kim, Hye Sun, Guven, Eylem Ozturk, Chen, Ya-Huey, Li, Long-Yuan, Hsu, Ming-Chuan, Coleman, Robert L., Calin, George A., Denkbas, Emir B., Lim, Jae Yun, Lee, Ju-Seog, Kundra, Vikas, Birrer, Michael J., Hung, Mien-Chie, Lopez-Berestein, Gabriel, Sood, Anil K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2923653/
https://ncbi.nlm.nih.gov/pubmed/20708159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccr.2010.06.016
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak